Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver Surgery
| Status: | Recruiting |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/21/2018 |
| Start Date: | August 17, 2018 |
| End Date: | December 31, 2019 |
| Contact: | Thomas Aloia |
| Email: | taaloia@mdanderson.org |
| Phone: | 713-792-6940 |
A Feasibility Study of Electronic Neurocognitive Screening Tools in Surgery
This trial studies how well electronic neurocognitive tools work in screening for mental
capability in patients who are undergoing liver surgery. Using electronic neurocognitive
screening tools may help to better assess mental impairment.
capability in patients who are undergoing liver surgery. Using electronic neurocognitive
screening tools may help to better assess mental impairment.
PRIMARY OBJECTIVES:
I. Evaluate feasibility of the electronic batteries, measured by the completion rate and time
to completion of the batteries.
SECONDARY OBJECTIVES:
I. Comparison of the completion rate and time to completion between the written and
electronic batteries.
II. Comparison of the scoring distribution between the screening tools.
EXPLORATORY OBJECTIVES:
I. Assess if a history of mental or cognitive illness or ongoing treatment with
neuropsychiatric medications impact the ability to complete written and/or electronic
neurocognitive screening.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients receive the BrainCheck cognitive assessment over 15 minutes followed by the
paper and pen cognitive assessment 1 month prior to surgery and 1 week after surgery.
GROUP II: Patients receive the paper and pen cognitive assessment followed by the BrainCheck
cognitive assessment over 15 minutes 1 month prior to surgery and 1 week after surgery.
I. Evaluate feasibility of the electronic batteries, measured by the completion rate and time
to completion of the batteries.
SECONDARY OBJECTIVES:
I. Comparison of the completion rate and time to completion between the written and
electronic batteries.
II. Comparison of the scoring distribution between the screening tools.
EXPLORATORY OBJECTIVES:
I. Assess if a history of mental or cognitive illness or ongoing treatment with
neuropsychiatric medications impact the ability to complete written and/or electronic
neurocognitive screening.
OUTLINE: Patients are randomized to 1 of 2 groups.
GROUP I: Patients receive the BrainCheck cognitive assessment over 15 minutes followed by the
paper and pen cognitive assessment 1 month prior to surgery and 1 week after surgery.
GROUP II: Patients receive the paper and pen cognitive assessment followed by the BrainCheck
cognitive assessment over 15 minutes 1 month prior to surgery and 1 week after surgery.
Inclusion Criteria:
- All English-speaking patients undergoing hepatectomy at main campus University of
Texas (UT)-MD Anderson Cancer Center who are cognitively able to provide informed
consent in the opinion of the attending physician.
We found this trial at
1
site
Houston, Texas 77030
Principal Investigator: Thomas A. Aloia
Phone: 713-792-6940
Click here to add this to my saved trials
